| Primary Device ID | 00365649850035 | 
| NIH Device Record Key | deb3c664-29a9-4a16-8813-38ea2ffe3bbb | 
| Commercial Distribution Status | In Commercial Distribution | 
| Brand Name | Solesta® | 
| Version Model Number | 1085003 | 
| Company DUNS | 793108036 | 
| Company Name | SALIX PHARMACEUTICALS, LTD. | 
| Device Count | 1 | 
| DM Exempt | false | 
| Pre-market Exempt | false | 
| MRI Safety Status | Labeling does not contain MRI Safety Information | 
| Human Cell/Tissue Product | false | 
| Device Kit | false | 
| Device Combination Product | false | 
| Single Use | true | 
| Lot Batch | true | 
| Serial Number | false | 
| Manufacturing Date | false | 
| Expiration Date | true | 
| Donation Id Number | false | 
| Contains Natural Rubber Latex | false | 
| Labeled No Natural Rubber Latex | false | 
| RX Perscription | true | 
| OTC Over-The-Counter | false | 
| Phone | 8005080024 | 
| salix@medcomsol.com | |
| Phone | 8005080024 | 
| salix@medcomsol.com | |
| Phone | 8005080024 | 
| salix@medcomsol.com | |
| Phone | 8005080024 | 
| salix@medcomsol.com | |
| Phone | 8005080024 | 
| salix@medcomsol.com | |
| Phone | 8005080024 | 
| salix@medcomsol.com | |
| Phone | 8005080024 | 
| salix@medcomsol.com | |
| Phone | 8005080024 | 
| salix@medcomsol.com | |
| Phone | 8005080024 | 
| salix@medcomsol.com | |
| Phone | 8005080024 | 
| salix@medcomsol.com | |
| Phone | 8005080024 | 
| salix@medcomsol.com | |
| Phone | 8005080024 | 
| salix@medcomsol.com | |
| Phone | 8005080024 | 
| salix@medcomsol.com | |
| Phone | 8005080024 | 
| salix@medcomsol.com | 
| Device Issuing Agency | Device ID | 
|---|---|
| GS1 | 00365649850035 [Primary] | 
| GS1 | 10365649850032 [Package] Package: Transport box [32 Units] In Commercial Distribution  | 
| LNM | Agent, Bulking, Injectable For Gastro-Urology Use | 
| Steralize Prior To Use | false | 
| Device Is Sterile | true | 
| Public Version Status | Update | 
| Device Record Status | Published | 
| Public Version Number | 3 | 
| Public Version Date | 2018-07-06 | 
| Device Publish Date | 2014-10-31 | 
| 00365649850035 - Solesta® | 2018-07-06SOLESTA® is indicated for the treatment of fecal incontinence in patients 18 years and older who have failed conservative therapy (eg. diet, fiber therapy, anti-motility medications). | 
| 00365649850035 - Solesta® | 2018-07-06 SOLESTA® is indicated for the treatment of fecal incontinence in patients 18 years and older who have failed conservative thera | 
| 00365649922039 - Deflux® | 2018-07-06 Deflux® is a bulking agent indicated for treatment of children with vesicoureteral reflux (VUR) grades II-IV. | 
Mark Image Registration | Serial  | Company  Trademark Application Date  | 
|---|---|
![]() SOLESTA  90465463  not registered Live/Pending  | 
        Galderma Holding S.A.  2021-01-14  | 
![]() SOLESTA  88090466  not registered Live/Pending  | 
        Néstlé Skin Health S.A.  2018-08-23  | 
![]() SOLESTA  78853445  3352167 Dead/Cancelled  | 
        NESTLÃ SKIN HEALTH S.A.  2006-04-04  |